GlaxoSmithKline is to manufacture 60 million doses of the COVID-19 vaccine developed by US biotech company Novavax for UK distribution, the British pharmaceutical giant said in a statement Monday. A statement from the company said they had reached an “agreement in principe” to make the doses at a plant in the northeast of England “beginning […]
Home »
GSK and Vir step up virus antibody treatment trials
British pharmaceutical giant GlaxoSmithKline (GSK) and Californian laboratory Vir Biotechnology on Tuesday announced final stage testing of their potential coronavirus treatment. The phase-three trials will evaluate the effectiveness of their “fully human anti-SARS-CoV-2 monoclonal antibody” VIR-7831 in the early treatment of patients at high risk of hospitalisation. If successful, the companies believe it could increase […]